One-year Prevalence, Comorbidities, and Cost of Hospitalizations for Alpha-1 Antitrypsin Deficiency among Patients with Chronic Obstructive Pulmonary Disease in the United States

One-year Prevalence, Comorbidities, and Cost of Hospitalizations for Alpha-1 Antitrypsin Deficiency among Patients with Chronic Obstructive Pulmonary Disease in the United States

**Objectives:** Little is known about severe chronic obstructive pulmonary disease (COPD) exacerbations among patients with Alpha-1 Antitrypsin Deficiency (AATD). We assessed inpatients with AATD and COPD among a sample of COPD inpatients to ascertain demographic, clinical and economic differences i...

Full description

Bibliographic Details
Main Authors: Christopher M. Blanchette, Emily Zacherle, Joshua M. Noone, Bryce A. Van Doren, Debosree Roy, Reuben Howden
Format: Article
Language:English
Published: Columbia Data Analytics, LLC
Series:Journal of Health Economics and Outcomes Research
Online Access:http://jheor.scholasticahq.com/article/9799-one-year-prevalence-comorbidities-and-cost-of-hospitalizations-for-alpha-1-antitrypsin-deficiency-among-patients-with-chronic-obstructive-pulmonary-disease-in-the-united-states.pdf

Internet

http://jheor.scholasticahq.com/article/9799-one-year-prevalence-comorbidities-and-cost-of-hospitalizations-for-alpha-1-antitrypsin-deficiency-among-patients-with-chronic-obstructive-pulmonary-disease-in-the-united-states.pdf

Similar Items